Skip to main content

REGENXBIO Inc.

RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001590877

In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 0 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding REGENXBIO Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of RGNX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1832172−9
Shares33.4M7.21K35.5M+2.14M (+6.4%)
Value$1.40B$301.0K$1.16B−$238.4M (−17.0%)

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held REGENXBIO Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to RGNX in Q4 2021
InstitutionSharesValue% of portfolio
Gyon Technologies Capital Management, LP93,329$3.05M0.56%
Banque Pictet & Cie SA72,062$2.36M0.02%
Harbor Capital Advisors, Inc.38,253$1.25M0.46%
Yousif Capital Management, LLC31,173$1.02M0.01%
Jackson Creek Investment Advisors LLC30,571$1.00M0.36%
HighVista Strategies LLC29,753$973.0K0.77%
Allspring Global Investments Holdings, LLC26,558$868.0K0.00%
Duality Advisers, LP22,301$729.0K0.08%
Engineers Gate Manager LP19,797$647.0K0.03%
Quantum Private Wealth, LLC18,373$600.0K0.23%
PDT Partners, LLC11,000$360.0K0.03%
Cresset Asset Management, LLC10,847$354.0K0.00%
AlphaCrest Capital Management LLC7,000$229.0K0.01%
Janus Henderson Group PLC6,479$212.0K0.00%
C M Bidwell & Associates Ltd4,325$141.0K0.09%
Point72 Hong Kong Ltd1,293$42.0K0.00%
Cambridge Trust Co370$12.0K0.00%
Eagle Bay Advisors LLC290$9.00K0.01%
CWM, LLC158$5.00K0.00%
Simplex Trading, LLC31$1.00K0.00%
Lenox Wealth Advisors, LLC26$1.00K0.00%
Covestor Ltd11$00.00%

Sold out (31)

Institutions that held REGENXBIO Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (2)

Institutions that held REGENXBIO Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RGNX in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Marshall Wace North America L.P.7,200$301.0K
Berman Capital Advisors, LLC14$0